Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?

Rifampicin is a key component of treatment for tuberculosis and its efficacy is determined by the blood levels attained after therapeutic doses. However, there is a high variability of rifampicin blood levels that is related to both the patient and the formulation used. To date, the effect of diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Adriana Aparecida Durães, Pinto, Ana Carla Godinho, Paixão, Thiago Portal da, Albério, Carlos Augusto Abreu, Vieira, José Luiz Fernandes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392073/
https://www.ncbi.nlm.nih.gov/pubmed/32535111
http://dx.doi.org/10.1016/j.bjid.2020.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392073/
https://www.ncbi.nlm.nih.gov/pubmed/32535111
http://dx.doi.org/10.1016/j.bjid.2020.05.007

Ejemplares similares